Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP)

Diffuse large B cell lymphoma (DLBCL) is clinically and biologically heterogeneous. In most cases of DLBCL, lymphoma cells coexpress vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2, suggesting autocrine in addition to angiogenic effects. We enumerated microvessel densit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gratzinger, Dita, Advani, Ranjana, Zhao, Shuchun, Talreja, Neha, Tibshirani, Robert J., Shyam, Ragini, Horning, Sandra, Sehn, Laurie H., Farinha, Pedro, Briones, Javier, Lossos, Izidore S., Gascoyne, Randy D., Natkunam, Yasodha
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2809124/
https://ncbi.nlm.nih.gov/pubmed/19821819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2009.07942.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados